BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1809811)

  • 1. Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections.
    De Simone C; Chiodo F; Delia S; Pastore G; Scalise G; Sorice F; Tonietti G; Zanussi C; Paoloni M; Gargiulo M
    J Chemother; 1991 Oct; 3(5):321-7. PubMed ID: 1809811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous sulbactam/ampicillin in the treatment of pediatric infections.
    Lee CY; Lin TY; Chu ML; Lee MJ; Hsu CY; Huang LM; Chen CM
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):179S-183S. PubMed ID: 2686918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies on sulbactam/ampicillin in the field of pediatrics].
    Iwata S; Yamada K; Sato Y; Ishikawa K; Akita H; Sunakawa K
    Jpn J Antibiot; 1989 Mar; 42(3):598-611. PubMed ID: 2664249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical evaluation of sulbactam/ampicillin in the treatment of pediatric infections.
    Huang LM; Lee CY; Lee MJ; Hsu CY; Liu CC; Hong JY; Chen JM
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(2):87-93. PubMed ID: 2637593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation.
    Dajani A
    J Int Med Res; 2001; 29(4):257-69. PubMed ID: 11675898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sultamicillin experiences in the field of internal medicine.
    Hara K; Kobayashi H
    APMIS Suppl; 1989; 5():51-6. PubMed ID: 2660872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ampicillin/sulbactam in lower respiratory tract infections: a review.
    Cunha BA
    Clin Ther; 1991; 13(6):714-26. PubMed ID: 1790546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
    Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
    J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trial.
    Güneren MF
    Drugs; 1988; 35 Suppl 7():57-68. PubMed ID: 3065055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of sulbactam plus ampicillin in the treatment of general pediatric infections.
    Bassetti D; Solbiati M; Ravelli A; Martini A; Viola S; Burgio RG
    APMIS Suppl; 1989; 5():41-4. PubMed ID: 2660870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of sultamicillin fine granules in lower respiratory tract infection].
    Takamoto M; Harada S; Harada Y; Kitahara Y; Ishibashi T; Shinoda A
    Jpn J Antibiot; 1988 Dec; 41(12):1841-6. PubMed ID: 3249357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulbactam/ampicillin followed by oral treatment with sultamicillin for medical and surgical infections.
    Chang ST; Chung HY; Pai SD; Lee JH
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):175S-178S. PubMed ID: 2686917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity of an ampicillin/sulbactam combination in respiratory infections].
    Mangiarotti P; Manara G; Grassi G; Gialdroni Grassi G
    G Ital Chemioter; 1989; 36(1-3):39-44. PubMed ID: 2488911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of ampicillin/sulbactam (Unasyn) in treating inflammatory urological diseases].
    Perepanova TS; Kotliarova GA; Kondrat'eva EM; Siniukhin VN; Derevianko II; Safin RN
    Antibiot Khimioter; 1991 Jun; 36(6):21-5. PubMed ID: 1898184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms.
    Syriopoulou V; Bitsi M; Theodoridis C; Saroglou I; Krikos X; Tzanetou K
    Rev Infect Dis; 1986; 8 Suppl 5():S630-3. PubMed ID: 3026016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on sultamicillin in pediatrics].
    Sekiguchi T; Miyazaki M; Nishimori M; Kozan S; Ohara K; Okamoto T
    Jpn J Antibiot; 1988 Dec; 41(12):1959-64. PubMed ID: 3249369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children.
    Kulhanjian J; Dunphy MG; Hamstra S; Levernier K; Rankin M; Petru A; Azimi P
    Pediatr Infect Dis J; 1989 Sep; 8(9):605-10. PubMed ID: 2677956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of sultamicillin in lower respiratory tract infections].
    Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Miyazaki N; Matsuzaki Y
    Jpn J Antibiot; 1991 Feb; 44(2):150-9. PubMed ID: 2041156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.